Variable | Stratification | Univariate HR (95% CI) | p-value | Multivariate HR (95% CI) | p-value |
---|---|---|---|---|---|
ER imaging | Positive | 2.84 (1.78–4.53) | <0.01 | 2.35 (1.44–3.83) | <0.01 |
Negative | 1 | reference | 1 | reference | |
Admission | Admitted | 2.12 (1.34–3.30) | <0.01 | 1.86 (1.16–2.97) | <0.01 |
Discharged | 1 | reference | 1 | reference | |
Cancer type | CNS tumors | 1.32 (0.72–2.43) | 0.38 | 1.45 (0.78–2.70) | 0.24 |
Hematologic malignancies | 0.28 (0.14–0.56) | <0.01 | 0.25 (0.13–0.50) | <0.01 | |
Neuroblastoma | 0.72 (0.41–1.28) | 0.26 | 0.62 (0.35–1.11) | 0.11 | |
Retinoblastoma | 0.82 (0.32–2.11) | 0.69 | 0.90 (0.35–2.33) | 0.83 | |
Others | 0.77 (0.36–1.67) | 0.51 | 0.64 (0.29–1.44) | 0.28 | |
Bone & soft tissue tumors | 1 | reference* | 1 | reference* | |
Gender | Male | 1.10 (0.73–1.66) | 0.66 | ||
Female | 1 | reference | |||
Age (years) | 11-18 | 0.95 (0.62–1.43) | 0.79 | ||
0-10 | 1 | reference | |||
No. ER visits | ≥3 | 2.96 (1.59–5.52) | <0.01 | 3.08 (1.62-5.83) | <0.01 |
2 | 1.97 (1.16–3.34) | 1.98 (1.15–3.41) | 0.01 | ||
1 | 1 | reference | 1 | reference |